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MOLECULAR CHARACTERISATION OF
MONOCYTE ESTERASE DEFICIENCY
N J Orr," 2 S L Cosby,' G M Markey,2 H D
Alexander2
1. Centre for Infection, Inflammation and Repair, The
Queen's University of Belfast.
2. Department of Haematology, Belfast City Hospital.
Monocyte specific esterase activity is a useful
marker for identification of cells of the
monocytemacrophage lineage. Atpresentlittle is
known about the in vivo role of MSE.
Epidemiologicalevidence suggestalinkbetween
monocyte esterase deficiency (MED) and
malignant neoplasia. Familial studies indicate
that the trait may have an autosomal dominant
pattern ofinheritance, which is uncommon foran
inherited enzyme deficiency. Monocyte esterase
deficient cells have a reduced ability to lyse
tumourcellsinvitro. Wearecurrentlyundertaking
an investigation into the molecular defect
responsible for MED. Sequence analysis of
genomic DNA from affected individuals is being
used to identify novel single nucleotide
polymorphisms (SNPs) in the MSE gene, Ces 1,
whichmaybelinkedto MED. Wehaveidentified
two novel SNPs in intron nine of Ces I in two
patients who originally presented with cancer of
thegastrointestinal tract(GI)tract. Sincegrowing
evidence suggests thattheMSE status ofpatients
with GI cancermay be significant in determining
an appropriate treatment strategy we aim to
determine whether these SNPs will be clinically
important.
PRIMARY CUTANEOUS LYMPHOMAS, THE
UNFORGOTTEN LESSONS
M AI-Hussaini, MY Walsh
DepartmentofPathology, RoyalGroupofHospitalsTrust,
Belfast.
Skinisthesecondmostfrequentsiteforextranodal
lymphomas following the gastrointestinal tract.
Beforeimmunohistochemistry was introduced in
the late 1970's, most cases were considered
malignant proliferations ofT-cells with mycosis
fungoides/Sezary syndrome being the classical
example. However, by using immunohisto-
chemical stains, it has been found that at least
25% ofallcasesofprimarycutaneouslymphomas
are ofB-cell origin. Even more recently, a small
subgroup of primary cutaneous lymphomas was
found to express the CD56 marker, and so was
classified as primary cutaneous lymphoma of
natural killer cells.
We are presenting three cases of primary
cutaneous lymphomas, two ofwhich are primary
cutaneous B-cell lymphomas and a case ofCD56
positive (natural killer) cutaneous lymphoma,
withspecialemphasisontheclinicalpresentation
and the histopathological and immunopheno-
typical patterns.
LYMPHOPLASMACYTOID LYMPHOMA AND
HAEMOLYTIC ANAEMIA
D Finnegan, M McHenry, G M Markey, H D
Alexander, T C M Morris
Department of Haematology, Belfast City Hospital,
Northern Ireland.
Lymphoplasmacytoid lymphoma is a low grade
lymphoproliferative disorder that may be
associated with cold haemagglutinin disease
(CHAD). We described a case of CHAD in a
patient with CD20positive lymphoplasmacytoid
lymphoma,resistanttostandardtherapies,treated
successfully with Rituximab (anti-CD20
antibody).
A 75 year old man present to our Haematology
outpatientdepartmentinMarch 1998withweight
loss, night sweats and increasing shortness of
breath. Full blood count revealed anaemia
(haemoglobin 6.2g/dL) with an elevated mean
cell volume (100 fL). A cold agglutinin and
serum lgMk paraprotein (13g/L) were present
and the direct Coombs test was positive. Serum
lactate dehydrogenase was markedly elevated.
Bonemarrowtrephinebiopsyshowedaninfiltrate
of lymphoplasmacytoid cells which was
paratrabecular and at times diffuse.
Immunohistochemical studies showedthesecells
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to be CD20 positive. Computerised tomography
showed a few enlarged lymph nodes in the para-
aortic and pelvic regions. Based on these results
a diagnosis of lymphoplasmacytoid lymphoma
with secondary cold haemagglutinin disease was
made.
The patient was treated with several courses of
chlorambucil and prednisolone. His
lymphadenopathy resolved but he continued to
haemolyze. Despite further courses of
chlorambucil and prednisolone, maintenance
prednisolone and warmed blood transfusions he
remained anaemic.
Following several recent reports on the use of
Rituximab in cold haemagglutinin disease we
commencedthispatientonRituximabatastandard
dose of 375mg/M2 once weekly for four weeks
(days 1, 8, 15 and 22). Rituximab therapy was
well tolerated and has resulted in control of
haemolysis with a normal haemoglobin, normal
lactatedehydrogenaseanddecreaseinparaprotein
level(to2g/L)despitecessationofsteroidtherapy.
This case emphasises that cold haemagglutinin
disease associated with an underlying
lymphoproliferative disorder remains a difficult
therapeutic problem and consideration shouldbe
giventotherapywithRituximabinpatientswhose
disease is resistant to standard therapies.
FOLLICULAR DENDRITIC CELL SARCOMA OF
THE MEDIASTINUM
KMDillon,CMHill,CHSCameron,RLAttanoos,
WG McCluggage
DepartmentofPathology,RoyalVictoriaHospital,Belfast.
Follicular dendritic cell sarcomas are extremely
rare, the majority occurring within lymph nodes.
They have, however, been described at extra-
nodal sites. We describe a recurrent follicular
dendritic cell (FDC) sarcoma occurring within
the soft tissues of the mediastinum in order to
raise awareness amongst pathologists of this
uncommon neoplasm.
An 84 year old lady presented with a posterior
mediastinal mass. Nineteen years earlier a mass
had been removed from the same location and
had been diagnosed as a "neurogenic tumour".
The recurrent tumour was well circumscribed,
andhistologically wascomposedofblandspindle
shapedcellswithinterspersedinflammatorycells,
predominantly lymphocytes. Immunohisto-
chemically the spindle cells were positive for
S100 protein, LCA, CD68 and vimentin, but
negative for CD21 and CD35 (markers of
follicular dendritic cells). Ultrastructural
examination demonstrated elongated cell
processes joined by desmosome-like junctions.
The ultrastructural features were diagnostic of
follicular dendritic cells.
FDC sarcomais arareneoplasmand ahighindex
ofsuspicionisrequiredinordertoreach acorrect
diagnosis. Immunohistochemistry and, or,
electron microscopy is required for a definitive
diagnosis. This case demonstrates that not all
cases are immunoreactive with CD21 and CD35
and illustrates the role ofelectron microscopy in
establishing a diagnosis.
AN UNUSUAL CASE OF ANAEMIA
IMainie,' J Hamilton,2 T C M Morris,2 D RHull'
1. Departments of Haematology, Craigavon Area
Hospital.
2. Belfast City Hospital.
A fifty year old female presented with Coombs
positivehaemolyticanaemia. Thiswasrefractory
tofirstline treatment. Search for aprimary cause
uncovered a solidareawithinthe liver. Biopsy of
this revealed a diffuse large cell B-cell Non
Hodgkin's Lymphoma. She received six courses
of CHOP resulting in rapid remission of her
haemolytic anaemia and lymphoma. Sixteen
months later she developed a right-sided buccal
swelling with simultaneous relapse of her
haemolytic anaemia. Repeat biopsy proved this
to be relapse of her large cell Non Hodgkin's
Lymphoma. Imaging showed no evidence of
relapse elsewhere. She proceeded to salvage
chemotherapyusingtheESHAPregimeandafter
one course her buccal swelling had reduced
completely and her haemolytic anaemia entered
asecondremission. Sheproceededto twofurther
courses ofESHAP and an autologous peripheral
blood stem cell transplantation.
There are less than 100 cases of primary extra
nodal lymphoma arising inthe liverreported and
although the association between
lymphoproliferative disorders and haemolytic
anaemia is well recognised there are no recorded
cases of primary B- cell Non Hodgkin's
Lymphoma of liver with associated haemolytic
anaemia in the literature.
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AN UNUSUAL PAROTID SWELLING
LakshmiVenkatraman, SS Napier, ClaireMHill,
DS Brooker'
1. Departments ofPathology and Otorhinolaryngology,
Royal Group of Hospitals, Belfast.
Unilateralparotidglandswellingwhenassociated
with facial nerve palsy is strongly suggestive of
malignancy. We report a case in which the
pathology indicated a very unusual presentation
of Wegener's granulomatosis in which the
involvement was subsequently shown to be
multisystem, in spite of the apparently localised
clinical presentation.
The patient, a previously healthy 65 year old
man, presented with a six week history of a
clinically malignant swelling ofhis right parotid
glandwithrightfacialnervepalsy. Theglandwas
surgically explored and histology revealed
necrosis, active inflammation and granuloma
formation, with a vasculitic process suggestive
of Wegener's granulomatosis. Subsequent
serological investigation indicated a cANCA of
320 (normal 0-19) and PR3 ANCA 13.4U/ml
(normal 0-2). The patient was diagnosed as
Wegener's granulomatosis with limited right
parotid involvement. He was treated with
corticosteroids, cyclophosphamide and voltarol.
Two weeks later he collapsed and subsequently
died following severe haematemesis.
Autopsy revealed massive gastrointestinal
haemorrhage from a 5cm diameter, deep
pyloroduodenalpepticulcerwithableedingartery
at its base.
Thearterydidnotshowanyhistologicalevidence
ofvasculitis butthere were lesions ofWegener's
granulomatosis in both lungs and in many other
organs including the left parotid gland.
This case highlights the fact that parotid
enlargement may be the presenting feature of
Wegener's granulomatosis and can mimic a
malignant tumour. Pathologists should keep this
inmindwhenfacedwithanunusualinflammatory
process in the head and neck andrecommend the
appropriate serological investigations to help
confirm the diagnosis.
SNOOKERED BY THE BLUES BROTHERS!
Melanie J Percy, Matthew J S Gillespie, Anne E
Hughes, Mary Frances McMullin & Terry R J
Lappin
Haematology Department, Belfast City Hospital,
Haematology Research Department, QUB, U Floor,
BCH.
Almost 60 years ago two brothers who were
deeply cyanosed came to the attention of a local
practitioner. He administered vitamin C to one
brother and this alleviated the cyanosis. Initially
this was thought to be due to congestive heart
failure but cardiologists later ruled out that
diagnosis. Analysis of the spectral properties of
thebrothers' haemoglobinresultedinthedetection
of methaemoglobin. A local biochemist Dr
Gibson, who was interested in the biochemical
pathway controlling the reduction of
methaemoglobin, intensively studied the
erythrocytes from these patients. Gibson was
able to elucidate the enzyme, now known as
NADH-cytochromeb5reductase,responsiblefor
methaemoglobin reduction and was the first
person to attribute a hereditary trait to a specific
enzyme deficiency.
Since the characterisation of the NADH-
cytochrome b5 reductase gene in the 1980s
numerous mutations have been detected in with
patients methaemoglobinaemia. To completethe
study initiated by Gibson the genetic lesion was
sought in the original blue brothers. Sequencing
of genomic DNA detected a heterozygous
mutation in exon 9 ofthe gene from one brother,
which causes an amino acid substitution thereby
making the enzyme less stable and hence non-
functional. This mutation was also detected in an
asymptomatic sibling. To complicate things the
level of functional enzyme is 1% in the original
brother therefore this mutation cannot account
forcompletelossofactivity. Anothermutationor
loss of expression of the normal b5 reductase
gene is being sought but remains elusive.
BASOPHIL-ACTIVATION MARKER ANALYSIS-A
NEW APPROACH TO DIAGNOSE DRUG
HYPERSENSITIVITY REACTIONS
MS Asghar, IM Aly Hassan, AD Crockard and
JDM Edgar
Regional Immunology Service, Royal Hospitals Trust,
Belfast
Type 1 hypersensitivity reactions to drugs are
reported to occur in 0.1% and 0.01% cases in
medical and surgical wards, respectively.'
Detection ofspecific1gE antibodies (RAST) and
skinpricktesting (SPT) is nothelpfulin all cases,
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anddiagnosis isusuallymadeonclinicalgrounds.
Flow cytometric assessment of drug induced
basophil activation may offer an additional
approach for diagnosis ofthese hypersensitivity
reactions. We report the use ofthis methodology
in the investigation of2 cases ofsuspected drug-
induced allergy.
Case 1: A 44-year old woman was referred to
Immunology after she experienced a Grade IV
reaction during exposure to general anaesthesia
with Suxamethonium as a muscle relaxant.
Elevated mast cell tryptase and urinary
methylhistamine were demonstrated post-
reaction. Suxamethonium-specific IgEantibodies
weredetectedandSPTwithSuxamethoniumwas
positive. In vitro induction, by Suxamethonium,
of CD63 expression on basophils was
demonstrated by flow cytometry.
Case 2: A 30-year old woman with history of
migraine was referred with recurrent episodes of
urticarial rashes and swelling of eyelids after
taking Paracetamol and Aspirin. RAST and SPT
to Paracetamol and Acetyl Salicylic acid were
negative. Drug challenge to both Paracetamol
and Aspirin in controlled environment proved
positive in two separate occasions. In vitro,
induction by Paracetamol, of CD63 expression
by basophils was demonstrated. Recently, drug
challenge with Vioxx (COX-2 inhibitor NSAID)
was negative.
Analysis ofbasophil activation may prove useful
in the investigation of drug induced hyper
sensitivity reactions, particularly when SPT and
RAST are negative or SPT cannot be performed
orincaseswhereclinical andlaboratoryevidence
is equivocal.
1. Vervloet D and Durham, S. Adverse Reactions to
Drugs. BMJ 1998: 316 (7143) 1511.
VASCULITIS PRESENTING AS PULMONARY
THROMBOEMBOLIC DISEASE
SSaleh, I CSilk,2JIsmail,3DDoyle,4MSheppard,5
L Burke'
1. Department of Histopathology, Cork University
Hospital, Eire.
2. Department of Rheumatology, Cork University
Hospital, Eire.
3. Department ofCardiology, CorkUniversityHospital,
Eire.
4. Department ofRadiology, Cork University Hospital,
Eire.
5. Department of Histopathology, Royal Brompton
Hospital, UK.
Vasculitis andthrombosis aretwoconditionsthat
canoccurinthepulmonarycirculation. However,
an association of these two conditions is rare.
Here we reported two cases of different types of
vasculitispresenting asthromboembolic disease.
The first case is a 34 year old female with a
knownhistoryofWegener'sgranulomatosis who
presentedwithshortness ofbreath. Investigations
revealed thrombosis and stenosis in the main
pulmonary arteries. Histological examination of
these large elastic arteries showed features of
Wegener's granulomatosis. Presentation as
thromboembolic disease and large elastic artery
involvement by Wegener's granulomatosis is
unusual andhasneverbeendescribedbefore. The
second case involves a 46 year old female who
also presented with shortness ofbreath, and was
clinically diagnosed and treated as chronic
thromboembolic disease with a subsequent
development of anti-coagulant and anti-
cardiolipinantibodies. Herconditiondeteriorated
andshedied. Histologicalexaminationofautopsy
specimens showed features ofgiant cell arteritis
involvingdistalmuscularpulmonary arteries. An
association of giant cell arteritis with anti-
phospholipid antibody syndrome has never been
reported. Thesecaseshighlighttheimportanceof
consideration of vasculitis in pulmonary
thromboembolic disease even when there is no
prior suspicion of a vasculitic process.
HER-2/NEU OVEREXPRESSION AND
AMPLIFICATION INBREASTCANCER: ADIRECT
COMPARISON OF IMMUNOHISTOCHEMISTRY
AND FLUORESCENCE IN-SITU HYBRIDISATION
(FISH)
M Jeffers, D O'Toole, H Magee, B Curran, J
O'Loughlin
DepartmentofCellularPathology, TheAdelaideandMeath
Hospital, Dublin and Department of Histopathology,
Trinity College Dublin.
Background: her-2/neu status is an important
prognostic and predictive factor in breast
carcinoma, and is central to selection ofpatients
for treatment with the humanised anti-her-2
monoclonal antibody (Herceptin). Accurate
assessmentofher-2 statusis,therefore,important
inthepathologicalevaluationofbreastcarcinoma.
There is no consensus on the preferred
methodology for assessment of her-2 status in
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breast cancer. This study was undertaken to
compare evaluation of her-2 status by
immunohistochemistry and by fluorescence in-
situ hybridisation (FISH).
Methods: her-2/neu status was evaluated in 83
consecutive unselected cases of invasive breast
carcinoma. All biopsies were fixed in formalin,
routinely processed and embedded in paraffin.
her-2/neu status was assessed by immunohisto-
chemistry (IHC) using the FDA approved
Herceptest (DAKO) and by fluorescence in-situ
hybridisation (FISH) using the PatVysion her-2
DNA kit (Vysis). IHC staining was evaluated by
themanufacturer'srecommendedscoringsystem
(score 0 to 3+). Cases scoring 0 or 1+ were
considered negative for her-2 overexpression,
cases scoring 2+ or 3+ were considered positive.
FISH was evaluated by the ratio ofher-2 signals
to chromosome 17 signals: a ratio of .2 was
considered amplified.
Results: 31/83 (38%) cases were positive by
IHC (11: 2+, 20: 3+), 52 were negative (32: 0+,
20: 1+). 17 (20%) cases exhibited her-2
amplification by FISH, 66 (80%) cases were not
amplified. The results of IHC and FISH were
discordantin 1/52IHCnegative cases (IHC score
0) and in 15/31 IHC positive cases. 10/1 1 (91%)
of IHC score 2+ cases were negative for
amplification, 5/20 (25%) ofIHC 3+ cases were
negative for amplification.
Conclusions: The results ofIHC forher-2 using
theDAKOHerceptestmethodcorrelatewellwith
amplification statusinnegative(score0/1+)cases.
Themajorityofcases scored2+ are notamplified
and these are considered to represent IHC false
positives. Cases scored 2+ on IHC should be
furtherevaluatedbyFISHiftherapeuticdecisions
are to be based on her-2 status.
HER-2 ANALYSIS IN TISSUE MICROARRAYS OF
ARCHIVAL HUMAN BREAST CANCER:
COMPARISON OF IMMUNOHISTOCHEMISTRY
AND FLUORESCENCE IN SITU HYBRIDISATION
C Flahavan, A O'Grady, E Kay, H Barrett, M
Leader
Department ofPathology, R.C.S.I. Education & Research
Centre, Smurfit Building, Beaumont Hospital, Dublin
9, Ireland.
HER-2 gene alterations have been shown to have
prognostic andpredictive value forthe treatment
ofbreastcancerpatients with therapeutic agents,
inparticular, themonoclonalantibody, Herceptin.
Because of this, the accurate and consistent
evaluation of HER-2 status is crucial. HER-2
status is assessed at the protein level
(overexpression) by immunohistochemistry
(IHC) and at the DNA level (gene amplification)
by fluorescence in situ hybridisation (FISH).
IHC is a reliable and economical test to assess
HER-2 status while FISH is regarded as the gold
standard method for detecting HER-2
amplification. Although the best approach is to
combinebothIHC andFISHassaysthisapproach
is not very practical or cost- effective forroutine
histopathological laboratories. The recent
developmentoftissuemicroarraytechnologyhas
allowedlarge-scalestudiesusingformalin-fixed,
paraffin-embedded material. We employed this
technique to assess HER-2 statusin acohortof54
invasive breast cancer cases by both IHC and
FISH assays to determine if the results obtained
wererepresentativeoftheprotein/geneexpression
patterns of the original whole tissue section.
Concordance for HER-2 IHC between the tissue
microarray and full sections was 93%.
ConcordanceforHER-2FISHbetweenthetissue
microarray and full sections was 91%.
Concordance between HER-2 FISH and HER-2
IHC on the tissue microarray was 98%. The use
of three cores per tumour adequately represents
the antigen expression on a whole tissue section.
Tothebestofourknowledgethis isthefirststudy
to validate the use oftissue microarray for FISH
assessment of HER-2. We conclude that tissue
microarrays provide highly comparable results
in the assessment of HER-2 protein levels and
allow large-scale analysis ofthe HER-2 gene by
FISH. The methodology described in this study
for HER-2 analysis is both time saving and cost-
effective and with minimal technical training is
suitable for use in a diagnostic setting.
FIRST REPORT OF CANDIDA DUBLINIENSIS
BLOODSTREAM INFECTION IN NORTHERN
IRELAND
RMcMullan,I XJiru,' BCMillar,I JEMoore,' MJ
Walker,2 JG Barr,2 ST Irwin,3 SA Hedderwick 4
1. Department of Microbiology, Belfast City Hospital,
Lisburn Road, Belfast.
2. Regional Mycology Reference laboratory, Royal
Victoria Hospital.
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3. Department of Surgery Royal Victoria Hospital,
Belfast.
4 Department of of Infectious Diseases, Royal Victoria
Hospital, Belfast.
A 35 year-old lady with metastatic carcinoma of
the uterine cervix had an episode of Candida
dubliniensis bloodstream infection (BSI)
following a laparotomy performed to repair a
broken down ileocolic anastomosis. She had
received broad spectrum antibacterial therapy
for two weeks prior to this for the treatment of a
polymicrobial septicaemia. In addition, a central
venouscatheterhadbeenplacedandshehadbeen
receivingtotalparenteralnutrition.Unfortunately,
the patient deteriorated and died three days
postoperatively; on the same day blood cultures
became positive with yeasts.
Therewereseveralinteresting issuesarisingfrom
this episode. Firstly, the described patient had
several typical risk factors for common candidal
BSI, but did not conform to any of the classical
profiles (neutropenic, peri-transplant or HIV-
seropositive) ofpatients withC. dubliniensisBSI
described in the literature.
Secondly, the case outlined might serve as a
reminder ofthe role forpre-emptive prescription
of an antifungal agent in the regimen of any
patient at risk of deep candidal infection failing
to improve despite apparently appropriate
antibacterial therapy.
Finally, the isolate was misidentified by routine
phenotypic methods as C. albicans. The
identification as C. dubliniensis was made,
producing 100% homology, by molecular
analysis. This raises the question whether more
discriminating methods should beroutinely used
forthephenotypic speciationofgermtubepositive
yeasts. Alternatively one might suggest that the
epidemiology of candidal BSI is important
enough, and phenotypic identification difficult
enough, to justify the routine use of molecular
methods to identify such isolates from blood.
PHENOTYPICMISIDENTIFICATIONOFCANDIDA
SPECIES
R McMullan,' X Jiru,1 BC Millar,, JE Moore,' R
McClurg,I SA Hedderwick 2
1. Department of Microbiology, Belfast City Hospital,
Lisburn Road, Belfast.
2. Department of Infectious Diseases, Royal Victoria
Hospital, Belfast.
Theaimofthe study wasto estimatethedegree of
error associated with phenotypic methods of
identifying Candida spp.
Retrospective identification of 39 isolates from
Candida stock was undertaken by sequencing of
the large internal transcribed spacer (ITS) region
(ie the ITS1- 5.8SrRNA-ITS2 region) which had
beeninitiallyrecoveredfrombloodbetween 1994-
2000 and were initially identified by phenotypic
methods. The molecular identity was taken to
representthe true identity when >98% homology
was achieved.
Of the 39 isolates tested, 5 were found to have
beenphenotypically misidentified. Critically, no
recurring pattern of error, such as any particular
speciesbeingrepeatedlymisidentified, was seen.
An isolate which had been initially thought to be
C. krusei was found to be C. tropicalis; an
unspeciated isolate which was initially
misidentified as C. norvegensis were found to be
C. krusei. One isolate phenotypically identified
as C. glabrata was found to be C. parapsilosis.
Two isolates had been initially misidentified as
C. albicans; one was genotypically identified as
C. glabrata and the other, C. dubliniensis.
Our study estimated an error rate of one in eight
phenotypic identifications; weconsiderthis tobe
unexpectedly substantial. Ifthe epidemiology of
Candida bloodstream infections is ofimportance
then we should further examine our phenotypic
methods of identification and perhaps consider
giving arole to molecularidentification methods
in routine practice.
MYXOPAPILLARYEPENDYMOMA, ANUNUSUAL
OUTCOME. CASE REPORT AND REVIEW OF
LITERATURE
M Al-Hussaini, B Herron, J W Gray
DepartmentofPathology,RoyalGroupofHospitais' Trust,
Belfast.
Ependymomasareprimarytumoursofthenervous
system which can occur in many locations.
However, there is an entity calledmyxopapillary
ependymomawhich occurs almostexclusively at
the cauda equina. They may cause surgical
difficulties of excision due to entrapment of the
spinal nerve roots and recurrence is occasionally
a problem. However, metastases are rarely
described. We wish to report the case of a
myxopapillaryependymomashowingwidespread
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metastatic dissemination throughout the
subarachnoid space in a 65 year old gentleman
fifteen years after initial diagnosis. One of the
metastatic foci caused atumourmass completely
filling the 4th ventricle andblocking the outflow
foramina causing hydrocephalus.
ANGIOLYMPHOID HYPERPLASIA WITH
EOSINOPHILIA, CASE REPORT AND REVIEW OF
LITERATURE
M Al-Hussaini, MY Walsh
DepartmentofPathology, Royal GroupofHospitals Trust,
Belfast.
Angiolymphoid hyperplasia with eosinophilia is
a rare disorder of uncertain histogenesis. It
presents clinically as single or multiple nodules
mostly around the head and neck region ofadult
patients. Because ofthevascularcomponent, itis
usuallymisdiagnosedclinically asangiosarcoma.
However, angiolymphoid hyperplasia with
eosinophilia has characteristic microscopy with
prominent nodular pattern. This is caused by
florid proliferation of blood vessels lined by
endothelial cells with a distinct epithelioid
appearance. These blood vessels are surrounded
by a mixture of inflammatory cells with
prominence ofeosinophils, thus the name.
We are reporting a case of an elderly lady who
presented with several nodules on the back of
several years duration. Histology showed the
typical vascular pattern and the associated
inflammatory component. Follow-up confirmed
the benign nature of the lesions.
C The Ulster Medical Society, 2002